IP Library Granted Patent US 8,691,580
Granted Patent B2
US 8,691,580 · App. 13/639,952 · Granted Apr 8, 2014

Single chemical entities and methods for delivery of oligonucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,580
App. No.
13/639,952
Granted
Apr 8, 2014
Kind
B2
Abstract

In an embodiment the instant invention discloses a modular composition comprising 1) an oligonucleotide; 2) one or more linkers, which may be the same or different, selected from Table 1, wherein the linkers are attached to the oligonucleotide at any 3′ and/or 5′ end; 3) one or more peptides, which may be the same or different, selected from SEQ ID NOs: 1-59, wherein the peptides are attached to the linkers; and optionally one or more lipids, solubilizing groups and/or targeting ligands attached to the oligonucleotide.

Claims (10)

1. A modular composition comprising 1) an siRNA; 2) one or more linkers, which may be the same or different, selected from the following linkers, wherein the linkers are attached to the siRNA at any 3′ and/or 5′ end;

and n=0 to 750;

and 3) one or more peptides, which may be the same or different, selected from SEQ ID NOs 1-59, wherein the peptides are attached to the linkers.

2. The modular composition of claim 1 wherein the linkers are attached to the guide strand of the siRNA at the 3′ and/or 5′ end.

3. The modular composition of claim 1 wherein the linkers are attached to the passenger strand of the siRNA at the 3′ and/or 5′ end.

4. A modular composition comprising 1) an siRNA; 2) one or more linkers, which may be the same or different, selected from the following linkers, wherein the linkers are attached to the siRNA at any 3′ and/or 5′ end;

and n=0 to 750;

and 3) one or more peptides, which may be the same or different, selected from SEQ ID NOs: 28, 29, 33, 35, 36, 40, 50, 51, 52, 53, 54, 55, 56, 57, 58, and 59, wherein the peptides are attached to the linkers.

5. The modular composition of claim 4 wherein the linkers are attached to the guide strand of the siRNA at the 3′ and/or 5′ end.

6. The modular composition of claim 4 wherein the linkers are attached to the passenger strand of the siRNA at the 3′ and/or 5′ end.

Assignments (3)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2014
From: MERCK SHARP & DOHME CORP.
To: SIRNA THERAPEUTICS, INC.
Reel/Frame 032584/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2013
From: AARONSON, JEFFREY; BARNETT, STANLEY F.; BARTZ, RENE'; COLLETTI, STEVEN L.; JADHAV, VASANT R.; MOMOSE, AARON A.; SHAW, ANTHONY W.; TELLERS, DAVID M.; TUCKER, THOMAS J.; WANG, WEIMIN; YUAN, YU
To: MERCK SHARP & DOHME CORP.
Reel/Frame 029619/0159 →